Literature DB >> 9427704

Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E.

S Rota1, N A McWilliam, T P Baglin, C D Byrne.   

Abstract

The importance of lipoproteins in the etiology of atherosclerosis is well established. Evidence is now accumulating to implicate thrombin in the pathogenesis of atherosclerosis. We have investigated whether atherogenic lipoproteins can support thrombin generation. In the absence of platelets or endothelial cells, both very low-density lipoprotein (VLDL) and oxidized low-density lipoprotein (LDL) support assembly of the prothrombinase complex and generation of thrombin. Thrombin generation (per microgram of apolipoprotein) supported by VLDL was 19.4-fold greater than that supported by high-density lipoprotein (HDL), P < .00001, and 11.7-fold greater than that supported by LDL, P < .00001. Oxidation of LDL increased lipoprotein-supported thrombin generation 12-fold compared to unmodified LDL, P < .0001. We have shown that the phenomenon of lipoprotein-supported thrombin generation is mediated predominantly by specific phospholipids and is enhanced by oxidation of these phospholipids. The addition of vitamin E (alpha-tocopherol) markedly reduced the increase in thrombin generation observed after oxidation of LDL (822 +/- 57 v 138 +/- 47 nmol/L; P < .0001). These effects suggest that lipoproteins are important in the production of thrombin and that vitamin E may confer protection from the detrimental effects of lipoprotein oxidation by limiting thrombin formation. These results suggest that atherogenic lipoproteins are linked to the development of atherosclerosis in part by their capacity to support thrombin generation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9427704

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Redox-regulation of haemostasis in hypoxic exercising humans: a randomised double-blind placebo-controlled antioxidant study.

Authors:  Lewis Fall; Julien V Brugniaux; Danielle Davis; Christopher J Marley; Bruce Davies; Karl J New; Jane McEneny; Ian S Young; Damian M Bailey
Journal:  J Physiol       Date:  2018-08-29       Impact factor: 5.182

Review 2.  Vitamin E: action, metabolism and perspectives.

Authors:  E Herrera; C Barbas
Journal:  J Physiol Biochem       Date:  2001-03       Impact factor: 4.158

3.  Juvenile patients with the homozygous MTHFR C677T genotype develop ischemic stroke 5 years earlier than wild type.

Authors:  Paul R J Ames; Giovanna D'Andrea; Vincenzo Marottoli; Alessia Arcaro; Luigi Iannaccone; Fabrizio Gentile; Maurizio Maraglione
Journal:  J Thromb Thrombolysis       Date:  2022-08-02       Impact factor: 5.221

4.  Liver Cirrhosis Patients Homozygous for MTHFR C677T Develop Portal Vein Thrombosis 8 Years Earlier Than Wild Type.

Authors:  Paul R J Ames; Giovanna D'Andrea; Alessia Arcaro; Vincenzo Marottoli; Luigi Iannaccone; Maurizio Maraglione; Fabrizio Gentile
Journal:  Dig Dis Sci       Date:  2022-08-24       Impact factor: 3.487

5.  Increased BMI and Blood Lipids Are Associated With a Hypercoagulable State in the Moli-sani Cohort.

Authors:  Romy de Laat-Kremers; Augusto Di Castelnuovo; Lisa van der Vorm; Simona Costanzo; Marisa Ninivaggi; Chiara Cerletti; Dana Huskens; Amalia De Curtis; Alessandro Gialluisi; Cuicui Bai; Giovanni de Gaetano; Dongmei Yin; Maria Benedetta Donati; Bas de Laat; Licia Iacoviello
Journal:  Front Cardiovasc Med       Date:  2022-06-16

6.  The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats.

Authors:  Jing Feng; Qing-shan Wang; Ambrose Chiang; Bao-yuan Chen
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

Review 7.  The hemostasis system in murine atherosclerosis.

Authors:  Takayuki Iwaki; Victoria A Ploplis; Francis J Castellino
Journal:  Curr Drug Targets       Date:  2008-03       Impact factor: 3.465

8.  High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.

Authors:  J H Griffin; K Kojima; C L Banka; L K Curtiss; J A Fernández
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy.

Authors:  Amanda P Waller; Jonathan P Troost; Samir V Parikh; Katelyn J Wolfgang; Brad H Rovin; Marvin T Nieman; William E Smoyer; Matthias Kretzler; Bryce A Kerlin
Journal:  Thromb Res       Date:  2021-02-16       Impact factor: 3.944

10.  Lowering Low-Density Lipoprotein Particles in Plasma Using Dextran Sulphate Co-Precipitates Procoagulant Extracellular Vesicles.

Authors:  Jiong-Wei Wang; Ya-Nan Zhang; Siu Kwan Sze; Sander M van de Weg; Flora Vernooij; Arjan H Schoneveld; Sock-Hwee Tan; Henri H Versteeg; Leo Timmers; Carolyn S P Lam; Dominique P V de Kleijn
Journal:  Int J Mol Sci       Date:  2017-12-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.